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AbsTRACT
background Globally, evidence about what works is 
slow to translate into frontline healthcare delivery. As a 
response, government policy has focused on translational 
health initiatives, such as the National Institute for 
Health Research funded Applied Research Collaborations 
in England. Concepts from organisation science prove 
useful to support such translational initiatives. We 
critique the application of two organisation science 
concepts linked to the broad domain of what is 
commonly termed ’knowledge mobilisation’ in healthcare 
settings, specifically ’knowledge brokers’ and ’absorptive 
capacity’, to provide lessons for leaders of translational 
initiatives.
Results The presence of knowledge brokers to ’move 
from what we know to what we do’ in healthcare 
delivery appears necessary but insufficient to have a 
system level effect. To embed knowledge brokers in 
the wider healthcare system so they draw on various 
sources of evidence to discharge their role with greatest 
effect, we encourage leaders of translational health 
research initiatives to take account of the concept of 
absorptive capacity (ACAP) from the organisation science 
literature. Leaders should focus on enhancing ACAP 
though development of ’co- ordination capabilities’. Such 
co- ordination capability should aim not just to acquire 
different types of evidence, but to ensure that all types 
of evidence are used to develop, implement and scale up 
healthcare delivery that best benefits patients. Specific 
co- ordination capabilities that support translation of 
evidence are: clinician involvement in research and 
its implementation; patient and public involvement in 
research and its implementation; business intelligence 
structures and processes at organisational and system 
level.
Conclusion Attention to the dimensions and 
antecedents of ACAP, alongside the implementation of 
the knowledge brokering solution, in translational health 
research initiatives, is likely to better ensure the latter’s 
success.
InTRoduCTIon
The gap between the production of evidence and 
service improvement is recognised as a challenge 
across the globe. This challenge has been char-
acterised as a ‘translation gap’ consisting of two 
dimensions: T1 ‘the translation of basic and clin-
ical research into ideas and products’ and T2 
‘introducing those ideas and products into clinical 
practice’. This article is concerned with bridging 
the second of these dimensions, the T2 gap.1 
Major translation initiatives have been devel-
oped to bridge this T2 gap in England, such as 
the recent investments in NHS Academic Health 
Science Networks (AHSNs) and Applied Research 
Collaborations (ARCs) by the National Institute 
for Health Research (NIHR). Such translational 
health research investments are evident globally, for 
example, in the USA, by the Department of Veterans’ 
Affairs Quality Enhancement Research Initiative. 
However, the T2 challenge persists stubbornly in 
both theory and practice. Studies have encouraged 
translational health research initiatives to encom-
pass insight from organisation science generated by 
business school researchers.2 Within this article, we 
highlight two organisation science concepts linked 
to the broad domain of what is commonly termed 
‘knowledge mobilisation’ in healthcare settings.3 
First, we critique the introduction of knowledge 
brokers to support translational health research as 
necessary but insufficient. Following which, second, 
we introduce the concept of ‘absorptive capacity’, 
the enhancement of which is crucial to support 
knowledge brokers’ roles in healthcare settings. 
We provide lessons for those leading translational 
health research initiatives, such as NIHR ARCs and 
NHS AHSNs.
KnowlEdgE bRoKERs
Many translational health research interventions 
rely on knowledge brokers, defined as those ‘who 
get the right knowledge, into the right hands, at the 
right time’.4 For example, one of the first NIHR 
Collaborations for Leadership in Applied Health 
Research and Care instituted in 2008, relied on 
‘diffusion fellows’, clinicians drawn from the front-
line of service that worked into translational health 
research teams, to drive evidence- based service 
improvement. In such arrangements, a clinician 
is allocated workload to work into an academic 
research team to coproduce a study, and then works 
outwards to diffuse study findings into practice so 
service improvement ensues.5 However, as a solu-
tion it has proved of limited effectiveness because 
knowledge brokers are few and far between within 
the wider system and its constituent organisations 
lack capacity to absorb knowledge produced by 
research.6 We also highlight a narrow focus on 
brokering of research evidence, may mean other 
knowledge, such as the tacit knowledge of clini-
cians gleaned from their practice7 and patient 
or carer experience of care, necessary for service 
improvement is not utilised. To address the chal-
lenge of embedding knowledge brokers in the wider 
healthcare system so they draw on various sources 
of knowledge to discharge their role with greatest 
effect, we encourage leaders of translational health 
research initiatives to take account of the concept of 
absorptive capacity (ACAP) from the organisation 
science literature.
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AbsoRpTIvE CApACITy
ACAP describes an organisation’s ‘ability to identify, assimilate, 
and exploit knowledge from the environment’.8
The concept of ACAP has been derived from studies in the 
private sector, but is increasingly being applied to examine vari-
ations in healthcare performance.9–12 The concept of ACAP can 
be applied to address the both the T1 and T2 translational gap.
There are four stages or dimensions around which we 
need to enhance ACAP of an organisation or system to effec-
tively acquire and use evidence. First, knowledge needs to be 
acquired, from different sources. Healthcare organisations and 
systems are relatively strong in this regard; that is, the problem 
is not one acquiring knowledge.13 Rather, the problem remains 
threefold around the other dimensions of ACAP. Some knowl-
edge is marginalised even as it is assimilated.14 Different 
sources of knowledge, even if assimilated, are not utilised or 
in ACAP terms, ‘transformed’ to develop and implement a 
service intervention, instead the status quo remains. Finally, 
even if transformation of knowledge does happen, evidence- 
based service improvement may remain local, and is not scaled 
up, or in ACAP terms ‘exploited’ for wider health gain because 
service interventions are not evaluated and lessons learnt not 
diffused.
The above gives rise to a gap between: (1) potential ACAP—
the ability to acquire and assimilate knowledge and (2) realised 
ACAP—the ability to put newly acquired knowledge into action 
within the organisation through transformation (the develop-
ment and piloting of an intervention) and exploitation (scaling 
up of that intervention). Such variance between potential and 
realised ACAP determines organisational performance.15
In order to move from potential to realised ACAP, both the 
organisation and its members need key capabilities to help bridge 
complex social systems. Those are called combinative capabili-
ties and are an important antecedent to developing ACAP and 
addressing variance between potential and realised ACAP. There 
are three combinative capabilities: (1) systems, (2) socialisation 
and (3) co- ordination capabilities. Systems capabilities refer to 
formal knowledge exchange mechanisms, such as written poli-
cies, procedures and manuals designed to facilitate transfer of 
codified knowledge, but also to environmental incentives that 
shape priorities. Socialisation capabilities refer to cultural mech-
anisms that promote a shared way of doing things and collec-
tive interpretations of reality within organisations. Coordination 
capabilities refer to lateral forms of communication such as 
education and training, facilitating leadership, cross- functional 
interfaces, collaborative learning strategies and distinct liaison 
roles. Empirical studies in private sector settings show that that 
variation in combinative capabilities influences ACAP. The tradi-
tional interaction of systems and socialisation capabilities are 
thought to stymie ACAP, though our position does not rule out 
the potential that novel combinations may in fact have a more 
positive influence. For example, regarding systems capabilities, 
policy emphasis on translational health research initiatives may 
or may not be outweighed by effect of austerity and performance 
management regimes. Meanwhile, regarding socialisation capa-
bilities, professional resistance to change can hinder innovation, 
but professional connectedness supports scale up. Moreover, 
coordination capabilities mediate the adverse effects of systems 
and socialisation capabilities on organisations pulling in knowl-
edge, and so enhance ACAP. The different balances between 
combinative capabilities are critical to understanding the ACAP 
of contexts which knowledge brokers are working within. It is 
therefore clearly important to understand these combinations 
further, particularly the positive effect of coordination capabili-
ties on ACAP.16
ACAp foR TRAnslATIonAl hEAlTh REsEARCh
In drawing on theoretical insights about ACAP, there are a 
number of ways in which leaders of translational health initia-
tives might assure their interventions are more successful. This 
relies in particular on enhancing co- ordination capabilities.17 We 
offer some specific suggestions.
In considering co- ordination capabilities, we need to ensure 
organisations and systems can encompass a range of knowledge 
beyond formal research evidence, specifically tacit knowledge 
held by clinicians gleaned from their practice and patient and 
carer experience of care. First, to ensure clinicians’ knowledge 
informs service improvement, clinician involvement in the devel-
opment, implementation and scale up of evidence- based service 
improvement through knowledge brokering roles undoubtedly 
remains an important component of enhancing coordination 
capability of healthcare organisations and systems. Such involve-
ment allows assimilation of clinicians’ internal, tacit knowledge 
that is gleaned from their everyday experience of delivering care 
with the external information acquired from ‘hard’ data collec-
tion systems around cost efficiency, clinical effectiveness and 
population health. As above, however, to move from potential 
to realised ACAP in a balanced way, requires clinician involve-
ment at all stages of the decision- making process so that the 
knowledge they hold is transformed and exploited. Their role as 
knowledge brokers in formal translational health research struc-
tures facilitates this. Following which, as well as enhancing their 
capabilities, there also needs to be incentives and opportunities 
for clinicians to participate in translational research.18
Meanwhile, second, to ensure patient and carer experi-
ence of care informs service improvement, patient and public 
involvement (PPI) has an important role as a part of the neces-
sary co- ordination capability. Importantly, this knowledge 
should not just be acquired, but assimilated with other, more 
traditional evidence about clinical effectiveness, cost efficiency 
and population health. However, PPI and the knowledge held 
by representatives is commonly marginalised during transfor-
mation and exploitation of evidence as more powerful actors 
hold sway.19 Managers within healthcare organisations should 
work to further integrate PPI mechanisms into all of knowledge 
mobilisation to improve their ACAP, and thus ensure all sources 
of evidence inform service improvement interventions and their 
scale up.
The more sources of relevant knowledge acquired and utilised 
the more likely service improvement ensues. In this light, the 
development of co- ordination capabilities should not just 
encompass clinician involvement and PPI, but, third, business 
intelligence structures and processes, to understand health at the 
population level and how existing services match (or not) this 
need. Organisations should recognise, however, this needs to 
go beyond information systems solutions, since the mobilisation 
of knowledge is ‘peopled’. To further enhance co- ordination 
capability, data analysts within the organisation need to work in 
real time with managers and frontline clinicians as problems are 
identified to ensure service improvement is derived from robust 
data held within healthcare organisations and systems.
Finally, in considering where clinician involvement, PPI and 
business intelligence generate ACAP, organisations need to 
consider all four stages or dimensions of ACAP. The tendency, 
specifically in healthcare, is that different knowledge is acquired, 
but then not not utilised.13 Particularly crucial is the exploitation 
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dimension of ACAP since healthcare organisations and systems 
are renowned for their failure to scale up evidence- based innova-
tion. Those leading translational health research initiatives need 
to fully examine what’s working, from whose perspective, what 
might we adapt as we scale up, and how we might glean resource 
for any potential scale up.18
In summary, attention to the dimensions and antecedents of 
ACAP, alongside the implementation of the knowledge brokering 
solution, in translational health research initiatives, is likely to 
better ensure the latter’s success.
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